Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

"So how do you hit multiple targets in the same go?" For their approach, Chen and his colleagues used a gene editing molecule called Cas13, which targets and degrades RNA. (Its more widely ...

"So how do you hit multiple targets in the same go?" For their approach, Chen and his colleagues used a gene editing molecule called Cas13, which targets and degrades RNA. (Its more widely ...

“So how do you hit multiple targets in the same go?” For their approach, Chen and his colleagues used a gene editing molecule called Cas13, which targets and degrades RNA. (Its more widely discussed ...

It is the most studied CRISPR gene editing technique, even if others exist like CRISPR-Cas12 or Cas13. The company was founded in 2017 with a focus on developing the technology of “base editing”.

CRISPR-Cas13 mediated editing of RNA corrects a common mutation in the retinal degeneration gene USH2A, and restores usherin expression in mouse photoreceptors when delivered with adeno-associated ...

Genetic engineering of animals has been recently revolutionized with the development of genome editing tools ... systems like Cas12 and Cas13. Genome editing provides an efficient approach for ...